SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Elbit spin-off Beyeonics Surgical seeks insolvency after raising tens of millions of dollars

Ashkelon to get $470 million industrial complex focused on semiconductors and deep tech

Arkia employees offered just 3% stake in rival takeover bid, with Sabbath flights to end

“Cooperation for 15 years”: The case for Europe as a long-term alternative to the US

Buzz

Most popular

Daily

Weekly

1

Colette Kress helped bring Israel to the heart of Nvidia's AI business. Now she's in charge.

2

ServiceNow is cutting jobs while committing hundreds of millions to acquired talent

3

Landwer Group among bidders for KFC Israel as chain collapses under NIS 50 million debt

4

eToro set for another round of layoffs as profits plunge and valuation slides

5

Dubai flights remain suspended as security dispute keeps Israeli airlines out of UAE

Colossal Biosciences

1 stories about Colossal Biosciences

Sam Lamm holding Romulus, one of the cubs

"We took a 73,000-year-old fossil and created puppies from it. It's just magic"

02.06.25|Roni Dori

Biotech venture Colossal Biosciences stunned the world in April with the announcement that it had genetically engineered the dire wolf, a species that went extinct 12,500 years ago. But the excitement over the birth of three white puppies was quickly tempered by criticism: skeptics argued this was not a true species revival and warned that such investments could divert attention and resources from the urgent effort to protect existing wildlife. In an exclusive interview, founder Ben Lamm explains how the complex process was achieved, and why he believes it could ultimately benefit the planet.